Is this you?
Request access for Precision Clinical Research using your company work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall74Recruit60Ops76Sponsor86Ther77
Performance (observed)
Historical trials
388
Completed
228
Terminated/Withdrawn
45
Completion rate
84%
Active now
107
Phase 2
108
Phase 3
207
Realized enrollment
569,199
First study year
2004
Years active
22
Match confidence
high
Enrollment velocity (inf)
25,873
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
347
States
Florida
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Pfizer; AbbVie; Eli Lilly and Company; Regeneron Pharmaceuticals; Amgen; Boston Scientific Corporation
CROs
ICON Clinical Research; IQVIA Pty Ltd; IQVIA Pvt. Ltd; Medpace, Inc.; PPD Development, LP; PRA Health Sciences
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall74
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.